What Probiotics Australia does

Probiotics Australia, operating as Specialty Probiotics Australia (SPA), is an Australian biotechnology research and contract manufacturing company headquartered in Ormeau, Queensland. Founded in 2009 and led by founder and CEO Craig Silbery, the company provides B2B probiotic manufacturing and microbiology services to health and wellness brands. Its operations are conducted within a TGA (Therapeutic Goods Administration) and cGMP (current Good Manufacturing Practice) certified facility and span the full production chain from fermentation through to finished product in multiple formats including encapsulation, sachets, and liquids.

The company's core asset is its probiotic strain library, which it describes as Australia's largest, with over 50 unique strains and 10 hero strains sourced through strategic partnerships with leading global probiotic suppliers. Building on this library, SPA offers an integrated service stack comprising concept and formulation development, ingredient sourcing, contract manufacturing, labeling, product testing, turn-key development, and reformulation services. The company targets an approximate 6-month timeline from lab to label and claims up to 25% cost optimization through source production, positioning these metrics as primary client value drivers.

The business model is B2B professional services revenue from contract manufacturing engagements, supplemented by ingredient supply to brands leveraging the strain library. Pricing is quote-based and project-driven with multi-year contract cadences; no public pricing is disclosed. Customer acquisition runs through direct B2B engagement via website contact forms and a LinkedIn presence, targeting enterprise and mid-market health and wellness brands that lack in-house probiotic manufacturing capability. The company has signaled an intent to expand into the Asian market and broaden its category footprint from probiotics into prebiotics and postbiotics.

Name

Probiotics Australia

Legal name

Specialty Probiotics Australia

Website

https://probioticsaustralia.com.au

Company type

Private

Founded year

2009

Operating status

Operating

Headcount range

11–50 employees

Short description

Probiotics Australia (Specialty Probiotics Australia) is an Australian biotech contract manufacturer offering end-to-end probiotic production services—including formulation, manufacturing, and turn-key development—for health and wellness brands, leveraging a 50+ strain library and TGA/cGMP certified facilities.

Ownership category

akta.pro rank

Product category

Probiotic Contract Manufacturing

NAICS

Pharmaceutical Preparation Manufacturing (325412), Packaging and Labeling Services (56191)

SIC

Food And Kindred Products (2000)

akta.pro primary industry

Probiotics (Human & Animal Strains, Spore-Formers, Synbiotic Bases) (AFAJAJAE)

akta.pro secondary industries

Probiotic, Prebiotic & Gut-Health Foods Manufacturing (Fermented Functional Foods, Synbiotics) (AFAKAJAH), Probiotic & Live-Culture Beverage Production (Shots, Tonics) (AFAFAHAE)

Keywords

• Probiotic contract manufacturing
• Probiotic strain library
• Microbiome product development
• TGA certified manufacturing
• Health supplement manufacturing

Headquarters

HQ city

Ormeau

HQ country

Australia

HQ region

Oceania

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Technology or R&D, Supply Chain, Infrastructure, Marketing or Sales

Revenue model

1. Contract Manufacturing Services: B2B probiotic manufacturing services including formulation development, ingredient sourcing, manufacturing, labeling, product testing, and turn-key product development for health and wellness brands.
2. Ingredient Supply: Supply of probiotic strains and ingredients to brands, leveraging their extensive strain library of over 50 unique probiotic strains.

Pricing tiers

Go-to-market motion1 record

Distribution channels2 records

Marketing channels2 records

Core offering

Probiotics Australia (legal entity Specialty Probiotics Australia) provides B2B contract manufacturing of probiotic products, supplying Australia's largest probiotic strain library with 50+ unique strains and delivering end-to-end services from concept and formulation development through ingredient sourcing, fermentation, encapsulation, labeling, and product testing. The company serves health and wellness brands with turn-key development in 6 months and reformulation support for existing products.

Product overview

Specialty Probiotics Australia operates as a contract manufacturing and product development services company offering an integrated probiotic production platform. The core offering centers on their extensive probiotic strain library with over 50 unique strains, complemented by a suite of manufacturing services including concept and formulation development, ingredient sourcing, contract manufacturing (encapsulation, sachets, and liquids), product labeling, testing, and turn-key development. The company enables brands to bring probiotic products from lab to label in approximately 6 months, with reported cost optimizations of up to 25% through source production from fermentation to finished product.

Differentiator

Problem solved

Functional benefit

Products and services

• Probiotic Strain Library

Quantifiable outcome

• 6 months from lab to label
• +2 more outcomes

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

One partnership is on record.

• World's Leading Probiotic Strain SupplierscoreStrategic or Co-development PartnerStrategic supplier partnerships providing access to the world's most clinically documented probiotic strains. These partnerships enable the company to offer over 50 unique strains and position Australia as a world-class location for probiotic and postbiotics ingredients manufacturing.

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Lallemand Health Solutions: Canadian-headquartered probiotic and biotics manufacturer offering probiotic strain production, formulation, and contract manufacturing for supplement and functional food brands worldwide. Directly comparable to Specialty Probiotics Australia as a B2B probiotic CDMO serving health and wellness brands with multi-format production.
• BIO-CAT: US-based probiotic contract development and manufacturing organization (CDMO) producing probiotic strains, blends, and finished formulations for dietary supplement and functional food brands. Closely comparable as a mid-sized probiotic CDMO with strain library and turnkey manufacturing capabilities.
• Probi AB: Swedish-listed probiotic ingredient and contract manufacturing company with clinically documented probiotic strains and B2B supply across supplements, food, and beverages. Comparable as a strain-library-led probiotic supplier and CDMO with global brand customers.
• Gnosis by Lesaffre: Business unit of Lesaffre focused on probiotic, yeast, and fermentation-derived nutritional ingredients with contract manufacturing for supplement brands. Highly comparable as a fermentation-based probiotic ingredient and CDMO serving health brands.

Broad incumbents

• Novonesis (formerly Chr. Hansen): Global bioscience major formed from the merger of Chr. Hansen and Novozymes, with one of the world's largest probiotic strain portfolios and CDMO capabilities across food, supplement, and infant nutrition. Comparable as a much larger, broad-portfolio incumbent probiotic manufacturer.
• Kerry Group: Ireland-headquartered global taste and nutrition company with a probiotic and functional ingredient portfolio serving supplement, beverage, and food brands. Comparable as a broad incumbent offering probiotic ingredients alongside a much wider nutrition portfolio.
• ADM (Archer Daniels Midland): Global agribusiness and nutrition major with a probiotics and biotics platform supplying ingredients to supplement and functional food brands. Comparable as a large incumbent that competes with boutique CDMOs on probiotic ingredient supply.
• IFF Health & Biosciences: Health and Biosciences division of International Flavors & Fragrants (IFF), offering probiotics, enzymes, and cultures with global manufacturing scale to food, beverage, and supplement customers. Comparable as a broad incumbent probiotic manufacturer with overlapping CDMO capabilities.

Regional players

• ProBio Inc. Taiwan-listed probiotic CDMO with strain development, fermentation, and contract manufacturing for supplement and functional food brands across the Asia-Pacific region. Comparable as an Asia-focused probiotic CDMO, relevant as Specialty Probiotics Australia targets the Asian market.
• Morinaga Milk Industry: Japanese dairy and functional ingredient company with a long-established probiotic (Bifidobacterium longum BB536) strain business and ingredient supply to global supplement brands. Comparable as a regionally anchored probiotic ingredient player with clinical-grade strain IP.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/specialty-probiotics-australia/?viewAsMember=true

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Probiotics Australia